Microsponges: a futuristic approach for oral drug delivery

Bibliography

• Turner S, Hite M, Federici C. Controlled delivery technologies applied to the nutraceutical industry. Pharm Manufacturing Packing Sourcer 2002; Autumn issue
   Google Scholar
• Ding X, Alani AWG, Robinson JR. Extended release and targeted drug delivery systems. In: Remington the science and practice of pharmacy. Volume 1 21st edition. Lippincott Williams and Wilkins, Philadelphia; 2002. p. 939-64
   Google Scholar
• Asghar LFA, Chandran S. Multiparticulate formulation approach to colon specific drug delivery: current perspectives. J Pharm Pharm Sci 2006;9(3):327-38
   PubMed Web of Science ®Google Scholar
• Josea S, Premaa MT, Chackoa AJ, Colon specific chitosan microspheres for chronotherapy of chronic stable angina. Colloids Surfaces B Biointerfaces 2011;83(2):277-83
   PubMed Web of Science ®Google Scholar
• Sabitha G, Punitha S, Saikrishna K, Formulation and evaluation of aceclofenac Microbeads-A chronotherapeutic approach. J Pharm Res 2011;4(12):4667-71
   Google Scholar
• Shivakumar HN, Suresh S, Desai BG. Design and evaluation of controlled onset extended release multiparticulate systems for chronotherapeutic delivery of ketoprofen. Indian J Pharm Sci 2006;68(1):76-82
   Google Scholar
• Sharma S, Pawar A. Low Density multiparticulate system for pulsatile release of meloxicam. Int J Pharm 2006;313(1):150-8
   PubMedGoogle Scholar
• Smith S, Morhenn V, Webster G. The characteristics and utility of solid phase porous microspheres: a review. J Drugs Dermatol 2006;5(10):969-74
   PubMedGoogle Scholar
• Embil K, Nacht S. The microsponge® delivery system (MDS): a topical delivery system with reduced irritancy incorporating multiple triggering mechanisms for the release of actives. J Microencapsul 1996;13:575-88
   PubMed Web of Science ®Google Scholar
• Sharma R, Pathak K. Polymeric nanosponges as an alternative carrier for improved retention of Econazole nitrate onto the skin through topical hydrogel formulation. Pharm Dev Technol 2011;16(4):367-76
   PubMed Web of Science ®Google Scholar
• Nacht S, Kantz M. The microsponge: a novel topical programmable delivery system. In: David WO, Anfon HA, editors. Topical drug delivery systems. Volume 42 Marcel Dekker; New York: 1992. p. 299-325
   Google Scholar
• Katz MA, Cheng CH, Nacht S. Methods and composition for topical delivery of benzoyl peroxide. US5879716; 1999
   Google Scholar
• Gans EH. Polymer Developments of cosmetic interest. Cosmet Toilet 1999;114:53-60
   Google Scholar
• Grimes PE. A microsponge formulation of hydroquinone 4% and retinol 0.15% in the treatment of melasma and postinflammatory hyperpigmentation. Cutis 2004;74(6):362-8
   PubMed Web of Science ®Google Scholar
• Srivastava R, Kumar D, Pathak K. Colonic luminal surface retention of meloxicam microsponges delivered by erosion based colon targeted matrix tablet. Int J Pharm 2010;427(2):153-62
   Google Scholar
• Kawashima Y, Niwa T, Takeuchi H, Preparations of controlled release microsponge and microballoon of ibuprofen with acrylic polymers by a novel quasi-emulsion solvent diffusion method. Proceed Int Symp Control Rel Bioactive Mater 1998;15:185-6
   Google Scholar
• Grochowicz M, Bartnicki A, Gawdzik B. Preparation and characterization of porous polymeric microspheres obtained from multifunctional methacrylate monomers. J Polymer Sci 2008;46:6165-74
   Web of Science ®Google Scholar
• Won R. Two step method for preparation of controlled release formulation. United States patent number. US5145675; 1992
   Google Scholar
• Jelvehgari MR, Siahi-Shadbad S, Azarmi GP, The microsponge delivery system of benzoyl peroxide: preparation, characterization and release studies. Int J Pharm 2006;308:124-32
   PubMed Web of Science ®Google Scholar
• Rawat A, Majumder QH, Ahsan F. Inhalable large porous microspheres of low molecular weight heparin: in vitro and in vivo evaluation. J Control Release 2008;128:224-32
   PubMed Web of Science ®Google Scholar
• Maiti S, Kaity S, Ray S, Development and evaluation of xanthan gum-facilitated ethyl cellulose microsponges for controlled percutaneous delivery of diclofenac sodium. Acta Pharm 2011;61:257-70
   PubMed Web of Science ®Google Scholar
• Bae SE, Son JS, Park K, Fabrication of covered porous PLGA microspheres using hydrogen peroxide for controlled drug delivery and regenerative medicine. J Control Release 2009;133:37-43
   PubMed Web of Science ®Google Scholar
• Mandal TK, Bostanian LA, Graves RA, Porous biodegradable microparticles for delivery of pentamidine. Eur J Pharm Biopharm 2001;52:91-6
   PubMed Web of Science ®Google Scholar
• Zaki Rizkalla CM, Latif Aziz R, Soliman II. In vitro and in vivo evaluation of hydroxyzine hydrochloride microsponges for topical delivery. AAPS PharmSciTech 2011;12(3):989-1001
   PubMed Web of Science ®Google Scholar
• Liu LS, Liu SQ, Ng SY, Controlled release of interleukin-2 for tumour immunotherapy using alginate/chitosan porous microspheres. J Control Release 1997;43:65-74
   Web of Science ®Google Scholar
• Lopez GP, Buranda T, Gopalaraju VRR, Biologically functionalized porous microspheres. US2004005352; 2004
   Google Scholar
• Trotta F, Cavalli R, Tumiatti W, Ultrasound-assisted synthesis of cyclodextrin-based nanosponges. EP1786841; 2005
   Google Scholar
• Pancholi K, Ahras N, Stride E, Novel electrohydrodynamic preparation of porous chitosan particles for drug delivery. J Mater Sci Mater Med 2009;20:917-23
   PubMed Web of Science ®Google Scholar
• Chadawar V, Shaji J. Microsponge delivery system. Curr Drug Deliv 2007;4(2):123-9
   PubMedGoogle Scholar
• Aritomi H, Yamasaki Y, Yamada K, Development of sustained release formulation of chlorpheniramine maleate using powder coated microsponges prepared by dry impact blending method. J Pharm Sci Technol 1996;56(1):49-56
   Google Scholar
• Pradhan SK. Microsponges as the versatile tool for drug delivery system. Int J Res Pharm Chem 2011;1(2):243-58
   Google Scholar
• Shaha V, Jain H, Krishna J, Microsponge drug delivery: a review. Int J Res Pharm Sci 2010;1(2):212-18
   Google Scholar
• Hong Y, Gao C, Shi Y, Preparation of porous polylactide microsphere by emulsion solvent evaporation based on solution induced phase separation. Polym Adv Technol 2005;16:622-7
   Web of Science ®Google Scholar
• Comoglu T, Gonul N, Baykara T. Preparation and in vitro evaluation of modified release ketoprofen microsponges. Il Farmaco 2003;58:101-6
   PubMedGoogle Scholar
• D’souza JI, More HN. Topical anti-inflammatory gels of flucinolone acetonide entrapped in eudragit based microsponge delivery system. Res J Pharm Technol 2008;1(4):502-6
   Google Scholar
• Kawashima Y, Niwa T, Takeuchi H, Control of prolonged drug release and compression properties of ibuprofen microspheres with acrylic polymer, eudragit RS, by changing their intraparticle porosity. Chem Pharm Bull (Tokyo) 1992;40(1):196-201
   PubMed Web of Science ®Google Scholar
• Barkai A, Pathak V, Benita S. Polyacrylate (Eudragit retard) microspheres for oral controlled release of nifedipine: formulation design and process optimization. Drug Dev Ind Pharm 1990;16:2057-75
   Web of Science ®Google Scholar
• Shah VP, Elkins J, Lam SY, Determination of In-vitro Release from Hydrocortisone Creams. Int J Pharm 1989;53:53-9
   Web of Science ®Google Scholar
• Comoglu T, Gonul N, Baykara T. The effects of pressure and direct compression on tabletting of microsponges. Int J Pharm 2002;242:191-5
   PubMed Web of Science ®Google Scholar
• Comoglu T, Savaser A, Ozkan Y, Enhancement of ketoprofen bioavailability by formation of microsponge tablets. Pharmazie 2007;62(1):51-4
   PubMed Web of Science ®Google Scholar
• Cui F, Yang M, Jiang Y, Design of sustained release nitrendipine microspheres having solid dispersion by quasi emulsion solvent method. J Control Release 2003;91:375-84
   PubMed Web of Science ®Google Scholar
• Graves R, Moiseyev R, Pamujula S, Spherical biodegradable microsponge particle for drug delivery. Am Assoc Pharm Sci J 2005;7(S2)
   Google Scholar
• Nokhodchi A, Jelvehgari M, Reza Siahi M, Factors affecting the morphology of benzoyl peroxide microsponges. Micron 2007;38:834-40
   PubMed Web of Science ®Google Scholar
• Anderson DL, Cheng CH, Nacht S. Flow characteristics of loosely compacted macroporous microsponge polymeric systems. Powder Technol 1994;78:15-18
   Web of Science ®Google Scholar
• Kramer A, Turk S, Vrecer F. Statistical optimization of diclofenac sodium sustained release pellets coated with polymethacrylic films. Int J Pharm 2003;256:43-52
   PubMed Web of Science ®Google Scholar
• Love FS, Taylor TS, Meeks RG, Non-woven towel with microsponges. US7426776; 2008
   Google Scholar
• Orlu M, Cevher E, Araman A. Design and evaluation of colon specific drug delivery system containing flurbiprofen microsponges. Int J Pharm 2006;318:103-17
   PubMed Web of Science ®Google Scholar
• Sevgi F, Yurdasiper A, Kaynarsoy B, Studies on mefanamic acid microparticles: formulations, in vitro release and in situ studies in rats. AAPS PharmSciTech 2009;10(1):104-12
   PubMedGoogle Scholar
• Giovagnoli S, Blasi P, Schoubben A, Preparation of large porous biodegradable microspheres by using a simple double-emulsion method for capreomycin sulfate pulmonary delivery. Int J Pharm 2007;333:103-11
   PubMed Web of Science ®Google Scholar
• Sun L, Zhou S, Wang W, Preparation and characterization of porous biodegradable microspheres used for controlled protein delivery. Colloids Surf A Physicochem Eng Aspects 2009;345(1-3):173-81
   Web of Science ®Google Scholar
• Product information sheet. Oral technology. A. P. Pharma, Inc., Redwood City, California, United States of America.
   Google Scholar
• Jain V, Jain D, Singh R. Factors affecting the morphology of eudragit s-100 based microsponges bearing dicyclomine for colonic delivery. J Pharm Sci 2010;100(4):1-8
   Google Scholar
• Devrim B, Canefe K. Preparation and evaluation of modified release ibuprofen microspheres with acrylic polymers (Eudragit) by quasi emulsion solvent diffusion method: effect of variables. Acta Pol Pharm Drug Res 2006;63(6):521-34
   PubMedGoogle Scholar
• Jain V, Singh R. Dicyclomine-loaded Eudragit®-based microsponge with potential for colonic delivery: preparation and characterization. Trop J Pharm Res 2010;9(1):67-72
   Web of Science ®Google Scholar
• Jain V, Singh R. Development and characterization of eudragit RS 100 loaded microsponges and its colonic delivery using natural polysaccharides. Acta Pol Pharm Drug Res 2010;67(4):407-15
   PubMed Web of Science ®Google Scholar
• Jain V, Singh R. Design and characterization of colon-specific drug delivery system containing paracetamol microsponges. Arch Pharm Res 2011;34(5):733-40
   PubMed Web of Science ®Google Scholar
• Kadam HM, Disouja JI, Yadav SB. Development of microsponge formulations of aceclofenac for chronotherapy of rheumatoid arthritis. Am Assoc Pharm Sci J 2010
   Google Scholar
• Dhawale SC, Bankar AS, Patro MN. Formulation and evaluation porous microspheres of 5- Fluorouracil for colon targeting. Int J PharmTech Res 2010;2(2):1112-18
   Google Scholar
• Korting HC, Schafer-Korting M. Carriers in the topical treatment of skin disease. Handb Exp Pharmacol 2010;197:435-68
   PubMedGoogle Scholar
• Menter A, Vamvakias G, Jorizzo J. One-week treatment with once-daily fluorouracil cream 0.5% in participants with actinic keratoses. Cutis 2008;81(6):509-16
   PubMed Web of Science ®Google Scholar
• Torne S, Darandale S, Vavia P, Cyclodextrin-based nanosponges: effective nanocarrier for Tamoxifen delivery. Pharm Dev Technol 2012
   PubMed Web of Science ®Google Scholar
• Ansari KA, Torne SJ, Vavia PR, Paclitaxel loaded nanosponges: in-vitro characterization and cytotoxicity study on MCF-7 cell line culture. Curr Drug Deliv 2011;8(2):194-202
   PubMed Web of Science ®Google Scholar
• Emanuele AD, Dinarvand R. Preparation, characterization and drug release from thermoresponsive microsphere. Int J Pharm 1995;118(2):237-42
   Google Scholar
• Trotta F, Cavalli R, Tumiatti W. Cyclodextrin-based nanosponges for drug delivery. J Incl Phenom Macrocyclic Chem 2006;56:209-13
   Web of Science ®Google Scholar
• Swaminathan S, Vavia PR, Trotta F, Formulation of betacyclodextrin based nanosponges of itraconazole. J Incl Phenom Macrocyclic Chem 2007;57:89-94
   Web of Science ®Google Scholar
• Swaminathan S, Cavalli R, Trotta F, In vitro release modulation and conformational stabilization of a model protein using swellable polyamidoamine nanosponges of beta-cyclodextrin. J Incl Phenom Macrocyclic Chem 2010;68:183-91
   Web of Science ®Google Scholar
• Cavalli R, Akhter AK, Bisazza A, Nanosponge formulations as oxygen delivery systems. Int J Pharm 2010;402(1-2):254-7
   PubMed Web of Science ®Google Scholar
• Hu SH, Liu TY, Liu DM, Nano-ferrosponges for controlled drug release. J Control Release 2007;121(3):181-9
   PubMed Web of Science ®Google Scholar
• Ll NH, Benson JR, Kitagawa N. Polymeric microbeads and method of preparation. International publication number. WO1995033553; 2003
   Google Scholar
• Ansari KA, Vavia PR, Trotta F, Cyclodextrin-based nanosponges for delivery of resveratrol: in vitro characterisation, stability, cytotoxicity and permeation study. AAPS PharmSciTech 2011;12(1):279-86
   PubMed Web of Science ®Google Scholar
• Swaminathan S, Pastero L, Serpe L, Cyclodextrin-based nanosponges encapsulating camptothecin: physicochemical characterization, stability and cytotoxicity. Eur J Pharm Biopharm 2010;74(2):193-201
   PubMed Web of Science ®Google Scholar
• Lee JB, Hong J, Bonner DK, Self-assembled RNA interference microsponges for efficient siRNA delivery. Nat Mater 2012;11(4):316-22
   PubMed Web of Science ®Google Scholar
• D’souza JI. The Microsponge drug delivery system: for delivering an active ingredient by controlled time release. Latest Rev 2008;6(3): Available from: www.pharmainfo.net [Accessed 11 Nov 2010]
   Google Scholar
• Dean RC Jr, Silver FH, Berg RA, Weighted collagen microsponge for immobilizing the bioactive materials. US4863856; 1989
   Google Scholar
• Kaity S, Maiti S, Ghosh AK, Microsponges: a novel strategy for drug delivery system. J Adv Pharm Technol Res 2010;1(3):283-90
   PubMedGoogle Scholar
• Martin A, Swarbick J, Cammarata A. Physical pharmacy-Physical chemical principles in pharmaceutical sciences. 3rd edition. Lippincott Williams and Wilkins; 1991. p. 527
   Google Scholar
• Kilicarslan M, Baykara T. The effect of the drug/polymer ratio on the properties of Verapamil HCl loaded microspheres. Int J Pharm 2003;252(1-2):99-109
   PubMedGoogle Scholar
• Aulton ME. Pharmaceutics: the science of dosage form design. 2nd edition. Churchill Livingstone; New York, USA: 2002. p. 201
   Google Scholar
• Aulton ME. Pharmaceutics: the science of dosage form design. 2nd edition. Churchill Livingstone; New York, USA: 2002. p. 133-4
   Google Scholar
• Nokhodchi A, Jelveghari M, Siahi MR, The effect of formulation type on the release of benzoyl peroxide from microsponges. Iranian J Pharm Sci 2005;1(3):131-42
   Google Scholar
• Washburn EW. Note on a method of determining the pore sizes in a porous material. Proc Natl Acad Sci USA 1921;7:115-16
   PubMed Web of Science ®Google Scholar
• D’souza JI. In-vitro Antibacterial and Skin Irritation Studies of Microsponges of Benzoyl Peroxide. Indian Drugs 2001;38(7):23
   Google Scholar